Pharmacology

Action Mechanism of Action Reference
INHIBITOR IL-33 receptor (ST2) inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pulmonary Disease, Chronic Obstructive 3 D029424 ClinicalTrials
Dermatitis, Atopic 2 D003876 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594385
FDA SRS 27TW751DTH